Science Explorer Back to mapMap
Institution · Hartcentrum Hasselt

Most cited papers from Hartcentrum Hasselt

What are the most cited papers from Hartcentrum Hasselt?

The most cited paper from Hartcentrum Hasselt is "Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial" (Marco Valgimigli et al., 2015), with 1,311 citations. Next come "Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)" (1,134) and "Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document" (982).

Showing 50 of 60 papers. Every paper with more than 109 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial Marco Valgimigli et al. · The Lancet Open access 18 Mar 2015 1,311
2 Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) M. Bolla, Hein van Poppel, Laurence Collette et al. · The Lancet Aug 2005 1,134
3 Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document Héctor M. García‐García, Eugene Patrick McFadden, Andrew A. Farb et al. · Circulation Open access 11 Jun 2018 982
4 Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911) M. Bolla, Hein van Poppel, Bertrand F. TOMBAL et al. · The Lancet 18 Oct 2012 873
5 Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk Marco Valgimigli et al. · New England Journal of Medicine Open access 28 Aug 2021 589
6 Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions Gregg W. Stone, David H Adams, William T. Abraham et al. · Journal of the American College of Cardiology Open access Jul 2015 589
7 A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement George Dangas et al. · New England Journal of Medicine Open access 16 Nov 2019 557
8 Cardiac rehabilitation in Europe: results from the European Cardiac Rehabilitation Inventory Survey Birna Bjarnason‐Wehrens, Hannah M. McGee, Ann‐Dorthe Zwisler et al. · European Journal of Cardiovascular Prevention & Rehabilitation Open access 18 Mar 2010 516
9 EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations Anton W. Langerak et al. · Leukemia Open access 24 Aug 2012 507
10 Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes Marco Valgimigli et al. · New England Journal of Medicine Open access Sep 2015 398
11 Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects Matthieu Allez, Konstantinos Κarmiris, Edouard J. Louis et al. · Journal of Crohn s and Colitis Open access 30 Jun 2010 341
12 Standardized End Point Definitions for Coronary Intervention Trials Héctor M. García‐García, Eugene Patrick McFadden, Andrew A. Farb et al. · European Heart Journal 30 Apr 2018 327
13 Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial Marco Valgimigli et al. · The Lancet 108 authors 25 Aug 2018 309
14 Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohnʼs disease after ileo-caecal resection A. Van Gossum, Olivier Dewit, Edouard J. Louis et al. · Inflammatory Bowel Diseases 19 Dec 2006 293
15 Effects of Tiotropium With and Without Formoterol on Airflow Obstruction and Resting Hyperinflation in Patients With COPD Jan Arie van Noord, Joseph L. Aumann, Eduard Janssens et al. · CHEST Journal Mar 2006 283
16 Zotarolimus-Eluting Versus Bare-Metal Stents in Uncertain Drug-Eluting Stent Candidates Marco Valgimigli et al. · Journal of the American College of Cardiology Open access 23 Feb 2015 280
17 Characterization of the Vaginal Micro- and Mycobiome in Asymptomatic Reproductive-Age Estonian Women Tiina Drell, Triin Lillsaar, Lea Tummeleht et al. · PLoS ONE Open access 23 Jan 2013 268
18 The continuous heart failure spectrum: moving beyond an ejection fraction classification Filippos K. Triposkiadis et al. · European Heart Journal Open access 8 Mar 2019 267
19 P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials Marco Valgimigli et al. · BMJ ReviewOpen access 16 Jun 2021 261
20 Bronchoalveolar Lavage Fluid Galactomannan for the Diagnosis of Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases Johan A. Maertens, Vincent Maertens, Koen Theunissen et al. · Clinical Infectious Diseases 3 Nov 2009 247
21 Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study Maylene Wong, Lidia Irene Staszewsky, Roberto Latini et al. · Journal of the American College of Cardiology Open access Sep 2002 246
22 5-Year Clinical Outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the Sirolimus-Eluting Stent in the Treatment of Patients With Multivessel De Novo Coronary Artery Lesions Patrick W.J.C. Serruys, Yoshinobu Onuma, Scot Garg et al. · Journal of the American College of Cardiology Open access 19 Feb 2010 244
23 Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial Sigmund Silber, Stephan Windecker, Pascal Vranckx et al. · The Lancet Apr 2011 229
24 Standardization of Fractional Flow Reserve Measurements Gábor G. Tóth, Nils P. Johnson, Allen Jeremias et al. · Journal of the American College of Cardiology Open access Aug 2016 223
25 Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing Frédéric Amant, Magali Verheecke, Iwona Włodarska et al. · JAMA Oncology 5 Jun 2015 220
26 Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology Uwe Zeymer, Héctor Bueno, Christopher Bull Granger et al. · European Heart Journal Acute Cardiovascular Care Open access Mar 2020 210
27 Amiodarone and the Development of ARDS After Lung Surgery W. Van Mieghem, Luc Coolen, Ines Malysse et al. · CHEST Journal Jun 1994 204
28 Beneficial neurohormonal profile of spironolactone in severe congestive heart failure Michel F. Rousseau, Olivier Gurné, Daniel A. Duprez et al. · Journal of the American College of Cardiology Open access Nov 2002 200
29 Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias Peter Vandenberghe, Iwona Włodarska, Lucienne Michaux et al. · Leukemia 19 Feb 2004 183
30 Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis Gaston R. Vantrappen, Louis J. Rutgeerts, P. Schurmans et al. · Digestive Diseases and Sciences May 1988 183
31 Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI Davide Capodanno, Kurt Huber, Roxana Mehran et al. · Journal of the American College of Cardiology Open access Jul 2019 169
32 4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New-Generation Drug-Eluting Stents Masanori Taniwaki, Giulio Giuseppe Stefanini, Sigmund Silber et al. · Journal of the American College of Cardiology Open access 12 Feb 2014 163
33 Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections Benson Ogunjimi et al. · Journal of Clinical Investigation Open access 6 Aug 2017 160
34 Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention? Sara Ariotti et al. · JACC: Cardiovascular Interventions Open access Mar 2016 159
35 Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management Giuseppe Andò et al. · Journal of the American College of Cardiology Open access211 authors May 2017 157
36 Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting Anna Franzone et al. · Journal of the American College of Cardiology Open access 28 Oct 2019 148
37 Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial Roberto Galea, Federico De Marco, Nicolas F. Meneveau et al. · Circulation Open access 6 Nov 2021 147
38 Efficacy, Tolerability, and Safety of Lanthanum Carbonate in Hyperphosphatemia: A 6-Month, Randomized, Comparative Trial versus Calcium Carbonate Alastair J Hutchison, Bart Maes, Johan Vanwalleghem et al. · Nephron Clinical Practice Open access 4 Apr 2005 143
39 Mechanisms of sex differences in atrial fibrillation: role of hormones and differences in electrophysiology, structure, function, and remodelling Katja E. Odening, Sebastian Deiß, Dagmara Dilling‐Boer et al. · EP Europace Open access 4 Sep 2018 142
40 Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes Mariusz Tomaniak, Ply Chichareon, Yoshinobu Onuma et al. · JAMA Cardiology Open access 26 Sep 2019 139
41 Lifelong endurance exercise and its relation with coronary atherosclerosis Ruben De Bosscher, Christophe Dausin, Piet Claus et al. · European Heart Journal Open access 4 Mar 2023 138
42 Two-Year Outcomes After First- or Second-Generation Drug-Eluting or Bare-Metal Stent Implantation in All-Comer Patients Undergoing Percutaneous Coronary Intervention Marco Valgimigli, Matteo Tebaldi, Marco Borghesi et al. · JACC: Cardiovascular Interventions Open access 11 Dec 2013 138
43 Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials Francesco Costa et al. · European Heart Journal ReviewOpen access 16 Nov 2022 137
44 Sensory Neuropathic Cough: A Common and Treatable Cause of Chronic Cough Robert W. Bastian, Abhay M. Vaidya, Kathelijne Delsupehe · Otolaryngology Jul 2006 136
45 Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial Patrick W.J.C. Serruys et al. · European Heart Journal Open access 7 Jun 2019 131
46 Severe Diarrhea in Renal Transplant Patients: Results of the DIDACT Study Bart Maes, Karine Hadaya, Bart De Moor et al. · American Journal of Transplantation Open access 29 Mar 2006 130
47 Prognostic Implications of Declining Hemoglobin Content in Patients Hospitalized With Acute Coronary Syndromes Sergio Leonardi et al. · Journal of the American College of Cardiology Open access 25 Jan 2021 129
48 Imaging of gastrointestinal and abdominal tuberculosis F. M.H.M. Vanhoenacker, A I De Backer, Bart Op de Beeck et al. · European Radiology Supplements 29 Jan 2004 129
49 Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients Johan A. Maertens, Kristel Buvé, Koen Theunissen et al. · Cancer 31 Dec 2008 129
50 Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses Toon Van Gorp, Joan Veldman, Ben Van Calster et al. · European Journal of Cancer Open access 6 Jan 2012 128

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.